The chronic lung diseases, asthma and chronic obstructive pulmonary disease (COPD), are
common affecting over 500 million people worldwide and causing substantial morbidity and …

Poor adherence to maintenance pharmacotherapy is a reality in asthma. Studies confirm
that when symptoms worsen, most patients increase short-acting β2-agonist (SABA) use …

BACKGROUND: In 2010, the Canadian Thoracic Society (CTS) published a Consensus
Summary for the diagnosis and management of asthma in children six years of age and …

Summary Background The Single combination budesonide–formoterol inhaler Maintenance
And Reliever Therapy (SMART) regimen reduces severe asthma exacerbations in patients …

Background Asthma is characterised by chronic inflammation of the airways and recurrent
exacerbations with wheezing, chest tightness and cough. Treatment with inhaled steroids …

Inhaled corticosteroid (ICS)-containing therapies are the mainstay of pharmacological
management of asthma. They can be administered alone or in combination with a long …

Background In mild asthma exercise-induced bronchoconstriction (EIB) is usually treated
with inhaled short-acting β2 agonists (SABAs) on demand. Objective The hypothesis was …

Objective To determine the comparative effectiveness and safety of current maintenance
strategies in preventing exacerbations of asthma. Design Systematic review and network …

Asthma is a chronic inflammatory disease of the lungs that poses a considerable health and
socioeconomic burden. Several risk factors work synergistically to affect the progression of …

Objectives Protopathic bias is a systematic error which occurs when measured exposure
status may be affected by the latent onset of the target outcome. In this article, we aimed to …